| Code | 9636D | ||||||||||
| MA number | 65/0034/22-S | ||||||||||
| Product Form: | tbl dsp 50x37,5 mg/325 mg (blis.OPA/Al/PVC//papier/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 65 - ANALGETICA - ANODYNA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 18.02.2022 |
| Validity: | 18.02.2027 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Doreta 37,5 mg-325 mg dispergovateľné tablety_09.2023.pdf
|
| SPC: |
SPC_Doreta 37,5 mg-325 mg dispergovateľné tablety_01_2024.pdf
|
| Safety feature | Yes |
| Data update: | 22.01.2024 |
